|Bid||0.000 x 0|
|Ask||0.000 x 0|
|Day's Range||7.860 - 8.290|
|52 Week Range||3.990 - 19.869|
|PE Ratio (TTM)||51.21|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Product development will be a key area of focus as cannabis companies plan capital investments. Two reasons behind the legalization of cannabis are the elimination of the illicit market and the consumer protection that comes from quality-controlled products. While cannabis products will be highly regulated, companies are working on and will continue to work on developing products that will entice non-users in the coming months.
LEAMINGTON, ON, July 17, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) is proud to announce the Company's planned expansion into Latin America and the Caribbean with the proposed acquisition of industry-leading companies in Colombia, Argentina, Jamaica and a right of first offer and refusal in respect of Brazil through a definitive share purchase agreement (the "Agreement") with Scythian Biosciences Inc. ("Scythian"). Aphria will acquire 100% of the issued and outstanding common shares of LATAM Holdings Inc. ("LATAM Holdings"), a direct, wholly-owned subsidiary of Scythian (collectively, the "Transaction").
LEAMINGTON, ON, July 12, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has signed a Memorandum of Understanding (the "MOU") with the British Columbia Liquor Distribution Branch ("BCLDB") to provide a portfolio of high-quality, branded cannabis and cannabis derivative products for sale in BC's adult-use market. Under the terms of the MOU, Aphria will supply more than 5,000 kg of high-quality cannabis in the first year of the agreement, which will be made available for sale online and at licensed retailers across the province. Adult-use consumers will be able to choose from a wide-ranging selection of Ontario and BC dried flower, pre-rolls and cannabis oils from the Company's portfolio of adult-use brands.
It's possible that four growers could control 60% of all Canadian marijuana production by the turn of the decade.
On July 11, Aurora Cannabis (ACB) (ACBFF) announced it had established an agreement with Evio Beauty Group to develop cosmetic products that are hemp-based and CBD-based. According to the press release, the CBD-based products will be infused with CBD (a cannabis compound), while the hemp-based products will be non-infused cosmetic products.
On July 10, Canopy Growth (WEED) (CGC) entered into an agreement to acquire Hiku Brands. Following the news, Canaccord Genuity raised Canopy Growth’s target price to $34 from the previous target of $32. Canaccord Genuity thinks that the Hiku Brands acquisition will help Canopy Growth enhance its retail presence in western Canada.
In the earlier parts of this series, we discussed EV-to-sales valuation multiples for some of the cannabis stocks (SEED). However, to get a better understanding of whether the cannabis sector is in the overbought or oversold territory, we’ll look at more than one valuation multiple. In this article, we’ll discuss how the EV-to-EBITDA (enterprise value to earnings before interest, tax, depreciation, and amortization) has changed over the last month.
In the earlier part of this series, we discussed that the overall cannabis sector’s forward EV-to-sales (enterprise value to sales) trended lower in the last month. In this part, we’ll look at the cannabis companies’ (HMLSF) valuation multiple compared to the median of 9.3x.
In this article, we’ll look at other sales catalysts for cannabis producers (SEED) such as Canopy Growth (WEED) (CGC), Aurora Cannabis (ACB) (ACBFF), and Aphria (APHQF).
LEAMINGTON, ON, July 9, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) will release its fourth quarter results for 2018 on August 1, 2018. Financial results are expected to be released at approximately 7:00am ET, through SEDAR and on Aphria's website at www.aphria.ca/investors. A conference call will be scheduled for 9:00am ET and will feature a presentation by Aphria executives followed by a question and answer period with analysts.
Given that a big portion of customers will transition from illicit sources to regulated legal sources, it’s reasonable to think that the initial products will be similar to what’s available in the illicit market. The popularity of various cannabis consumption methods could guide the product landscape design for cannabis companies (MJ) such as Canopy Growth (CGC) (WEED), Aurora Cannabis (ACB), and Aphria (APHQF).
Aphria (APHQF) is one of the top medical cannabis licensed producers in Canada. It closed at 11.75 Canadian dollars, which was far from 20.19 Canadian dollars at the start of this year. To see how Aphria compares with companies (HMMJ) such as Aurora Cannabis (ACB) and Canopy Growth (WEED) (CGC), read Comparing Major Cannabis Players’ Prices and Cost Structures.
LEAMINGTON, ON, July 5, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has signed a Supply Agreement (the "Agreement") with the Alberta Gaming, Liquor & Cannabis Commission ("AGLC") to provide a portfolio of high-quality cannabis and cannabis-derivative products for sale in Alberta's adult-use market.
LEAMINGTON, ON , July 5, 2018 /CNW/ - Aphria Inc. (" Aphria " or the " Company ") ( TSX: APH and US OTC: APHQF ) announces that it has successfully completed the divestiture of the ...
LEAMINGTON, ON, June 29 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has signed a Supply Agreement (the "Agreement") with the Manitoba Liquor and Lotteries Corporation ("MBLL") to provide a portfolio of high-quality, branded cannabis and cannabis derivative products for sale in Manitoba's adult-use market. "We are thrilled to finalize this Agreement with the MBLL," said Jakob Ripshtein, Chief Commercial Officer at Aphria.
LEAMINGTON, ON, June 28, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX:APH.TO - News) (OTCQB: APHQF) is pleased to announce it has closed its short form prospectus offering, on a bought deal basis, including the exercise in full of the underwriters' over-allotment option. A total of 21,835,510 common shares (the "Shares") of the Company were sold at a price of $11.85 per Share, for aggregate gross proceeds of $258,750,794 (the "Offering"). The Offering was underwritten by a syndicate of underwriters led by Clarus Securities Inc. and included Canaccord Genuity Corp., Cormark Securities Inc., Haywood Securities Inc. and INFOR Financial Inc. (collectively, the "Underwriters").
While Canada has become the primary focus market for cannabis producers (HMMJ) such as Canopy Growth (WEED)(CGC), Aurora Cannabis (ACB), Aphria (APHQF), and MedReleaf (MEDFF), international markets have also gained significant traction. For example, in the fourth quarter, Germany accounted for ~10% of Canopy Growth’s medical cannabis sales, and German sales grew 120% YoY (year-over-year), according to Canopy. This momentum helped the company get a higher price per gram sold. In the fourth quarter, Canopy Growth’s price per gram sold rose YoY to an average of 8.40 Canadian dollars from 8. ...
Last week, lawmakers in Canada approved Bill C-45, which legalizes cannabis in Canada, with a 52–29 vote. This approval was anticipated, and cannabis stocks rallied last week. The Horizons Marijuana Life Sciences ETF (HMMJ) rose about 7% between the closing on June 15 and the closing on June 22. Let’s look at how other stocks reacted in this period.
The Canadian recreational marijuana market is now set to explode. And these three stocks could, too.
LEAMINGTON, ON, June 21, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that its Malta-based subsidiary ASG Pharma ("ASG"), a high-capacity EU GMP-certified lab, is the recipient of the first import license for medical cannabis issued by the Malta Medicines Authority ("MMA"). The license will allow ASG to import medical cannabis for analytical testing and research and is an important step that will enable ASG to become a cornerstone in testing, research and development of medical cannabis in Europe.
There are five phases marijuana stocks will likely go through after Canada's historic vote to legalize recreational cannabis.
Vic Neufeld, CEO of Aphria, said, "This is a historic milestone for our industry and for our country that will reverberate around the world as Canada solidifies its progressive leadership on cannabis. "Today also represents an important milestone for our business, for which all of us at Aphria have been eagerly awaiting," said Neufeld. Backed by our annualized production capacity of 255,000 kg by early next year, we are well prepared to the meet the anticipated demand in the adult-use market while continuing to serve the ongoing needs of our medical cannabis patients.